Cite
HARVARD Citation
Yazici, Y. et al. (n.d.). Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee. Osteoarthritis and cartilage. pp. S503-. [Online].